Company profile: Rovers
1.1 - Company Overview
Company description
- Provider of cancer-screening medical devices, designing, developing, and manufacturing self-sampling and diagnostic tools including Evalyn Brush for at-home HPV screening; Anex Brush for anal cancer screening; Orcellex Brush for oral cancer screening; Viba-Brush and Delphi Screener for cervical cancer self-sampling; and Cervex-Brush for comprehensive cervical cell collection.
Products and services
- Cervex-Brush®: A single-device cervical cancer screening brush that collects ectocervical, endocervical, and transformation-zone cells from the cervix, combining these samples with one device
- Delphi Screener: A lavage-based self-sampling device for cervical cancer screening that collects high-quality vaginal samples without scraping via a lavage method
- Evalyn® Brush: A self-sampling device that collects vaginal/cervical specimens to screen for HPV, allowing women to take samples at home
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Rovers
Theraclion
HQ: France
Website
- Description: Provider of high-intensity focused ultrasound (HIFU) echotherapy medical equipment, combining HIFU with standard ultrasound for non-invasive treatment and target localization. Solutions include SONOVEIN for varicose veins; ECHOPULSE for thyroid nodules and breast fibroadenoma; CURE-OP for combinational cancer therapy integrating ultrasound with radiotherapy; and EPack single-use disposables for cooling and coupling.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Theraclion company profile →
CoStim
HQ: United States
Website
- Description: Provider of antibody agents for cancer treatment and urban regeneration, construction, energy, and digital solutions, including the ChorusLife smart human district, general contracting (Impresa Percassi), construction envelope design and manufacturing (Gualini), global energy services (Elmet), and the GSM Platform for sustainable urban transformation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CoStim company profile →
TechniScan Medical Systems
HQ: United States
Website
- Description: Provider of ultrasound breast imaging and diagnostic systems, developing and commercializing systems for breast imaging and diagnosis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TechniScan Medical Systems company profile →
Rain Oncology
HQ: United States
Website
- Description: Provider of precision oncology therapies targeting oncogenic drivers, developing milademetan, an oral small molecule inhibitor of the p53-MDM2 complex for various cancers. Clinical programs include MANTRA (Phase 3 in dedifferentiated liposarcoma), MANTRA-2 (Phase 2 in TP53 wildtype/MDM2-amplified solid tumors), and MANTRA-4 (Phase 1/2 with atezolizumab in CDKN2A loss, TP53 wildtype tumors).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Rain Oncology company profile →
Gilupi
HQ: Germany
Website
- Description: Provider of medical devices and diagnostic solutions for in vivo isolation and analysis of rare circulating cells from blood. Offers GILUPI CellCollector for enriching circulating tumor cells, liquid biopsy sampling, immunofluorescence microscopy, NuPLex technology for RNA detection, and next-generation sequencing for genetic analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gilupi company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Rovers
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Rovers
2.2 - Growth funds investing in similar companies to Rovers
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Rovers
4.2 - Public trading comparable groups for Rovers
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →